Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Lupin

Lupin

BSE: 500257|NSE: LUPIN|ISIN: INE326A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jun 25, 11:19
914.05
9.15 (1.01%)
VOLUME 104,935
LIVE
NSE
Jun 25, 11:19
914.60
11.7 (1.3%)
VOLUME 1,562,489
News on Lupin
Select Year: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Lupin to launch nearly 30 products in US market this fiscal

5.11 pm | 24 Jun 2018 |  Source: PTI

The Mumbai-based company currently has 162 abbreviated new drug applications (ANDAs) pending approval with the US Food and Drug Administration (USFDA)...

Lupin gets USFDA approval for generic contraceptive drug

6.02 pm | 14 Jun 2018 |  Source: PTI

The drug is also used to treat moderate acne for women at least 14 years old besides to raise folate levels in women who choose to use an oral contrac...

Lupin gains 3% on USFDA approval for pregnancy prevention tablets

3.15 pm | 14 Jun 2018 |  Source: Moneycontrol.com

The company has received final approval for its Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Tablets and Levomefolate Calcium Tablets....

Buy Lupin, target Rs 954: Achin Goel

11.21 am | 14 Jun 2018 |  Source: Moneycontrol.com

Traders can accumulate the stock in the range of Rs 860-868 for the target of Rs 954 and a stop loss below Rs 824, says Achin Goel of Bonanza Portfoli...

Top 12 expert moneymaking ideas for the next 30 days

8.14 am | 11 Jun 2018 |  Source: Moneycontrol.com

Experts see the Nifty consolidating this week with a positive bias. “The bullish momentum is likely to continue as long as it holds above 10,550 lev...

Lupin launches generic drug in US

2.52 pm | 04 Jun 2018 |  Source: PTI

Lupin's product is the generic equivalent of Novartis Pharmaceuticals Corp's Methergine which is indicated for prevention and control of postp...

Lupin stock rises 2% on launch of drug that prevents postpartum hemorrhage

2.23 pm | 04 Jun 2018 |  Source: Moneycontrol.com

Methylergonovine Maleate tablet is the generic equivalent of Novartis Pharmaceuticals Corporation's Methergine....

Lupin launches specialty women health drug Solosec in US

12.56 pm | 31 May 2018 |  Source: Moneycontrol.com

Analysts estimate the drug to hit peak sales of USD 100 million per annum in next four years...

Buy or sell: Top stock trading ideas by market experts which are good short term bets

9.27 am | 31 May 2018 |  Source: Moneycontrol.com

Mitessh Thakkar of mitesshthakkar.com recommends buying Bajaj Finance with a stop loss of Rs 2099 and target of Rs 2160 and Indian Oil Corporation wit...

Lupin's biosimilar Etanercept accepted by Europe drug regulator for review

1.47 pm | 25 May 2018 |  Source: Moneycontrol.com

Lupin said it is on course with its plans for biosimilar Etanercept filing in the US and is targeting the same in FY 2019-20...

Buy Lupin; target of Rs 930: Centrum

4.21 pm | 23 May 2018 |  Source: Moneycontrol.com

Centrum is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 930 in its research report dated May 16, 2018....

Buy Lupin; target of Rs 865: Motilal Oswal

3.25 pm | 23 May 2018 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 865 in its research report dated May 15, 2018....

Hold Lupin; target of Rs 785: KR Choksey

5.47 pm | 21 May 2018 |  Source: Moneycontrol.com

KR Choksey recommended hold rating on Lupin with a target price of Rs 785 in its research report dated May 17, 2018....

These top 10 stocks can return up to 55% in 1 year

12.26 pm | 17 May 2018 |  Source: Moneycontrol.com

Analysts feel India, which imports more than 80 percent of its oil requirements, can manage to absorb up to $80 per barrel but beyond that it coul...

Worst over on US pricing pressure: Lupin tells Rakesh Jhunjhunwala in an interaction

2.22 pm | 16 May 2018 |  Source: Moneycontrol.com

India’s second-largest drug maker on Tuesday posted a massive net loss of Rs 783.5 crore in the fourth quarter ended March due to a one-time impairm...

Lupin posts net loss of Rs 783.5 crore in Q4 due to one-time impairment

3.21 pm | 15 May 2018 |  Source: Moneycontrol.com

The company reported a net profit of Rs 383.6 crore in the period previous year ago. The sales fell 2.8 percent to Rs 4179 crore....

Lupin Q4 PAT may dip 0.5% YoY to Rs. 380 cr: HDFC Securities

12.55 pm | 20 Apr 2018 |  Source: Moneycontrol.com

Net Sales are expected to decrease by 10.6 percent Y-o-Y (down 4.4 percent Q-o-Q) to Rs. 3,800 crore, according to HDFC Securities....

Lupin Q4 PAT may dip 18.5% YoY to Rs. 309.8 cr: Edelweiss

6.21 pm | 16 Apr 2018 |  Source: Moneycontrol.com

Net Sales are expected to decrease by 8.4 percent Y-o-Y (down 2 percent Q-o-Q) to Rs. 3,895.1 crore, according to Edelweiss....

Lupin Q3 disappoints, profit tanks 65% to Rs 222 cr; margin contracts sharply 

2.59 pm | 06 Feb 2018 |  Source: Moneycontrol.com

Operating profit at Rs 689 crore (down 43.5 percent YoY) and margin at 17.3 percent (contracted 990 basis points YoY) were far lower than analyst esti...

1 2 3
Quick Links for Lupin
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.